1 / 3

Blinatumomab price in India

Blinatumomab is a bispecific CD19-directed CD3 T-cell engager that is known to bind to CD19 (expressed on cells of B-lineage origin) and CD3 (expressed on the T-cells). The blinatumomab price in India can fluctuate depending on different factors. In order to procure blinatumomab, kindly get in touch with us at TOLL-FREE: 1800-889-1064. This medication is authorized as a second-line treatment for Philadelphia chromosome -Ve relapsed or refractory acute lymphoblastic leukemia (ALL). We're the leading supplier of blinatumomab, based in India.

jhon28
Télécharger la présentation

Blinatumomab price in India

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Blincyto : Treatment for ALL Overview The good news is that now there is a therapy or treatment for detectable traces of disease. Blincyto is the first and only FDA-approved therapy for individuals with a certain type of Acute Lymphoblastic Leukemia who are in the remission but have detectable traces of cancer following chemotherapy. About Medication Indication: The blincyto (blinatumomab) specifically is an immunotherapy. It is different from the chemotherapy because it engages the immune (defense) system to find and kill malignant cells. Blinatumomab is introduced as a prescription medication for treating B-cell precursor acute lymphoblastic leukemia (ALL) in adult patients who still have detectable traces of cancer following chemotherapy. The approval of this drug in these patients population is based on a outcomes that demonstrates response rate and duration of response. Blinatumomab can be prescribed in children, too. It is the first and only therapy of MRD+ B-cell precursor acute lymphoblastic leukemia for any age population. It is also got approved for such children whose B-cell precursor Acute Lymphoblastic Leukemia has returned or didn’t respond to treatment. Administration: The medicine blinatumomab is given by an intravenous (IV) infusion into the vein. Dosing of this medication occurs in cycles. Initial cycle is four weeks of infusion followed by two weeks without infusion. In the study of blinatumomab, most individuals got one or two cycles. Your health specialist will specify how long you will need to stay on the therapy.

  2. Preparing for Treatment: Blinatumomab treatment starts in the hospital in order to monitor and treat you for any severe reactions to the medication. You will also be given a medicinal product to help scale down the likelihood of infusion reactions. A hospital stay of three days is recommended for the 1'st cycle. For the 2'nd cycle, a stay of 2 days is required. After these stays, your health specialist will help you determine when you can go home. You will continue Blinatumomab with a tiny portable pump. The medication will require to be refilled every 1 to 7 days by a health specialist. Call your health specialist promptly in case you've any kinda complications with your pump or the alarm sounds. Real Time Experience with BLINCYTO Therapy: Hi, My name is Joanna, I'm living with B-cell precursor ALL (Acute Lymphoblastic Leukemia) and enjoying absolutely an active and Quality of Life..! As far as I remember, it was Boxing Day, when I got several tests done to see what turbulence actually indulged in my life. Eventually, I found out it was B-cell precursor Acute Lymphoblastic Leukemia. That’s where everything kinda seemed to a screeching halt. At that time, I completely knew What Acute Lymphoblastic Leukemia actually is? I was aware about what complications I'm going to face from this juncture of my life. I was trying to wrap my head around all these certain things. You know, in which way this gonna affect me? You know, how am I going to pay for my treatment or therapy? Treatment for Acute Lymphoblastic Leukemia requires spending longer time-spans in hospital, so individuals who had been working had to take extended sick leave from their jobs and the work had to be handed over to colleagues. With time consumed recovering at home after in-patient therapy, absences from work typically lasted few months, and sometimes more than a year. Many individuals went back to their work following their illness, but after such a long period of break could be a bit challenging, mainly because individuals had less energy and usually tired easily. Maximum had returned to their light duties at initial or part-time and gradually extended their hours. I turned down all my work projects because I might not have been able to finish them. I need to consider the first choice with treatment for me. My Doctor Jonathan suggested that I must look into a therapy named BLINCYTO (blinatumomab injection), so I went home, and researched it and I whispered BLINCYTO is appropriate for me. Apart from Dr. Jonathan, Indian Pharma Network based in Noida India, helped me a lot to smoothly get the Best Quality BLINCYTO.

  3. Although, I was so fortunate to get diagnosed with ALL earlier than usual. Indian Pharma Network said, "We're not only giving the Best Quality Medication for your disease, but also offering complete therapy that has a fixed timeframe and affordable blincyto price. The life of individuals with B-cell precursor ALL (Acute Lymphoblastic Leukemia) is full of ups and downs. I trusted BLINCYTO (Blinatumomab), and today I feel that it was the right decision, and right choice for me. Source - https://namepatientprogram.blogspot.com/2022/01/treatment-with-blinatumomab.html

More Related